Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
3
Bearish filings
6
Named actors
7
Disclosed $ (bull / bear)
size unknown / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-07-17 | 5%+ holder (13G) Paradigm Biocapital Advisors LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-04 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-06-03 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-02-17 | 5%+ holder (13G) Bellevue Group AG | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-17 | 5%+ holder (13G) JANUS HENDERSON GROUP PLC | disclosed a passive stake (13G) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2025-10-25 | Chief Executive Officer Tom Frohlich | adopted a selling plan | — | SEC ↗ |
| 2025-10-25 | Chief Scientific Officer & Head or Research and Development Andrew King | adopted a selling plan | — | SEC ↗ |
| 2025-10-25 | Chief Financial Officer Brad Dahms | adopted a selling plan | — | SEC ↗ |
| 2025-10-25 | Chief Legal Officer and Corporate Secretary Elizabeth Balta | adopted a selling plan | — | SEC ↗ |